Latest News about ESPR
Recent news which mentions ESPR
From Benzinga
From Benzinga
From Benzinga
Tickers
ESPR
From Motley Fool
From Benzinga
Esperion Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 21, 2022
Tickers
ESPR
From Benzinga
From Benzinga
From Benzinga
73 Biggest Movers From Yesterday
February 23, 2022
From Benzinga
Esperion Therapeutics (ESPR) Q4 2021 Earnings Call Transcript
February 22, 2022
Tickers
ESPR
From Motley Fool
50 Stocks Moving In Tuesday's Mid-Day Session
February 22, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 22, 2022
From Benzinga
Earnings Scheduled For February 22, 2022
February 22, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
February 07, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
January 07, 2022
From Benzinga
10 Biggest Price Target Changes For Thursday
December 09, 2021
From Benzinga
10 Biggest Price Target Changes For Monday
December 06, 2021
From Benzinga
58 Biggest Movers From Friday
December 06, 2021
From Benzinga
Mid-Afternoon Market Update: DocuSign Drops Following Weak Revenue Forecast; Longeveron Shares Climb
December 03, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 03, 2021
From Benzinga
Mid-Day Market Update: Nasdaq Dips Over 400 Points; Marvell Technology Shares Rise Following Upbeat Earnings
December 03, 2021
From Benzinga
41 Stocks Moving In Friday's Mid-Day Session
December 03, 2021
From Benzinga
Mid-Morning Market Update: Markets Open Lower; Big Lots Issues Weak Profit Forecast
December 03, 2021
From Benzinga
Esperion Shares Fall After $225M Capital Raise Via Equity
December 03, 2021
Tickers
ESPR
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 03, 2021
From Benzinga
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
December 03, 2021
From Benzinga
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.